In this episode of The Scalpel’s Edge, Dr. Tim Sayed reviews a newly published study from Colombia examining outcomes in women with breast implant illness following explant surgery. With over 125 patients and 18 months of follow-up, this research reveals significant improvements in symptoms such as joint pain, fatigue, and hair loss — and offers valuable insight into the science, skepticism, and evolving understanding of BII. Dr. Sayed breaks down the data, discusses parallels with U.S. studi...
All content for The Scalpel's Edge is the property of Dr. Tim Sayed and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of The Scalpel’s Edge, Dr. Tim Sayed reviews a newly published study from Colombia examining outcomes in women with breast implant illness following explant surgery. With over 125 patients and 18 months of follow-up, this research reveals significant improvements in symptoms such as joint pain, fatigue, and hair loss — and offers valuable insight into the science, skepticism, and evolving understanding of BII. Dr. Sayed breaks down the data, discusses parallels with U.S. studi...
Ep. 18 - GLP1 Medications Heart Health and Environmental Impact
The Scalpel's Edge
25 minutes
2 months ago
Ep. 18 - GLP1 Medications Heart Health and Environmental Impact
On this episode of The Scalpel’s Edge we explore a fascinating new study showing how GLP1 medications like semaglutide and tirzepatide may not only improve heart failure outcomes but also reduce greenhouse gas emissions. As I break down this meta-analysis presented at the European Society of Cardiology Congress you will hear how these drugs can deliver benefits for individual patients while also contributing to global sustainability efforts. Small improvements at the patient level may add up ...
The Scalpel's Edge
In this episode of The Scalpel’s Edge, Dr. Tim Sayed reviews a newly published study from Colombia examining outcomes in women with breast implant illness following explant surgery. With over 125 patients and 18 months of follow-up, this research reveals significant improvements in symptoms such as joint pain, fatigue, and hair loss — and offers valuable insight into the science, skepticism, and evolving understanding of BII. Dr. Sayed breaks down the data, discusses parallels with U.S. studi...
